NJ Bio, Inc.

NJ Bio, Inc. is a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) that provides integrated chemistry and biology services to biotechnology and pharmaceutical companies. Specializing in antibody-drug conjugates (ADCs) and bioconjugation, the company supports programs from early-stage discovery through GMP manufacturing, delivering highly tailored and innovative solutions to accelerate the development of complex targeted therapies for patients.